Layoff-Restructuring

Quote

anonymous said:
Get a report, we all have them, why do you think Marcy wants TP to sell both indications for Austedo next year. She watched TP grow an Azilect product that TN couldn't move.

Then came Zecuity, TRX was pretty basic report to read, but clearly you are a moron. Here is the explanation, TN accounted for 19% of Zecuity shipments.

Now here is Austedo, 50% of TN and a six month head start, but the shitty education sales force that we all crack up in the office is about to be passed by 1/3 of the TP teams for TOTAL ENROLLMENTS in just two months. TN sells both, has six months more and still gets passed before the year ends.

Any questions? Keep plugging away with those "patient programs" and TP will keep selling. Want further proof, wait until next June when Cop 40 is gone and your division has to launch Fre at the same time as TP but with each group having their own call panel. TN is shit and has been since the 2012 and 2013 mass exodus.
Click to expand...


TP sucks balls. Total waste of space. Your end is near.
 

anonymous said:
You lazy clueless bad food ... any TN rep worth anythung left years ago. You do nothing but patient programs and oh wah wah the gold standard for 20 years is now a couple times a eeek vs daily wah wah ... shut up get off the band wagon that we sampled too much? We use resources it’s part of the job fool, Samples aren’t scripts we grew that drug. Everything was going great until Teva acquired us which is what eveeyine says before Teva bough them ... just shut up everyone is tired if the TN eletist, spoiled attitude truly just SHUT UP
Click to expand...


You sound like a tool. Just saying'
 
We ALL need to be worried!
10,000 is a lot of cutting!

Why Shares of Teva Are on the Rise

Bloomberg Video•December 8, 2017


Dec.08 -- Teva Pharmaceutical Industries Ltd. is considering cutting as many as 10,000 jobs as new CEO Kare Schultz seeks to pare costs, according to people with knowledge of the matter. Bloomberg's Abigail Doolittle reports on "Bloomberg Markets."
 
For Teva Specialty to be successful going forward, they should merge the 2 sales forces and re-align geographies which should result in minor head count reduction in some locations. The toxic culture and dislike between the 2 sales forces is old and honestly just boring. The fact that reps are still on here trying to argue who is the better sales force is just stupid. Having 2 sets of leadership teams and 2 sales forces that can't stand each other is stupid and a waste of money and duplicate effort is wasteful. Streamline the sales structure until there is clear profit margins established and expand accordingly. Get smart Teva...that usually results in positive outcomes!
 
anonymous said:
For Teva Specialty to be successful going forward, they should merge the 2 sales forces and re-align geographies which should result in minor head count reduction in some locations. The toxic culture and dislike between the 2 sales forces is old and honestly just boring. The fact that reps are still on here trying to argue who is the better sales force is just stupid. Having 2 sets of leadership teams and 2 sales forces that can't stand each other is stupid and a waste of money and duplicate effort is wasteful. Streamline the sales structure until there is clear profit margins established and expand accordingly. Get smart Teva...that usually results in positive outcomes!
Click to expand...



LETS RALLY TEAM!!!!!!!!
 
anonymous said:
Wow! You are as clueless as you are clearly a dumbass. Show me one drug in any class that does not increase their pricing structure yearly if not quarterly. And the only reason y’all are still working (which mostly likely is a massive overstatement in your situation) is because of Copaxone. You should keep drinking the kool-aid though...seems to be working well! Even if 50% of revenues were lost by a generic entrant(s), Copaxone STILL delivers you a paycheck every two weeks because unlike you TN actually makes Teva money rather than bleeding us out.
Seeing y’all have all but dropped the ball time and time again, oh I’m sorry wait. I forgot like someone said before, “Amrix is just blowing it out of the water!” And if you are insinuating that the “decrease in Copaxone” revenue has anything to do with TN, wake up and see that like when TNP lost their baby Azilect (which lost teva more than we made because y’all sampled like it was candy on Halloween night) this is a bigger picture thing we don’t control. Being a new concept for y’all, TN actually continues to work during the day unlike most of our “counterparts”.
And my personal favorite, “Other branded medicines in this space continue to drastically decrease Teva's share and has become the trend since the inception of competitors in MS.“ Your friends at Genezyme or Biogen must be as incompetent & in doubt as much as you. Your trolling efforts are devine, but unfortunately your sources are as pathetic as yourself.
Click to expand...


Every TP rep has been in neuro for years or decades and we know you fake calls daily it must be soooooo hard working your 10 mile radius geography with a mirrored counterpart and don’t forget to do your 10 million patient programs that’s a great use of company funds COCKY IDIOTS!
 


Write your reply...
Top Bottom
Back
Quote